1.	Study of the Effectiveness of Cevimeline on Oral Health in Patients With Radiation Induced Xerostomia Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: AAO-101, NCT00466388
2.	A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: APC-10U1101, NCT01283906
3.	Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: Any Age Sponsor: Pharmaceutical / Industry Protocol IDs: CDX-353-002, NCT01660633
4.	Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 20040212, UCLA-0412042-01, AMGEN-20040212, NCT00109031
5.	Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000651536, RTOG-0920, NCT00956007
6.	Acupuncture in Treating Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer Phase: Phase III Type: Supportive care Status: Active Age: Not specified Sponsor: NCI, Other Protocol IDs: 2010-0547 MDA, MDA-04-01, CDR0000674208, 2010-0547, NCT01141231
7.	Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000675520, NCCTG-N09C6, N09C6, NCT01156142
8.	Xerostomia Acupuncture Trial Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2010-0584, NCT01266044
9.	Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Phase: Phase III Type: Supportive care Status: Active Age: 4 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000695718, COG-ACCL1031, ACCL1031, NCT01305200
10.	A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-034, NCT01355926
11.	CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000727295, NCCTG-N11C5, N11C5, NCT01545687
12.	Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 603EUSA03, NCT00901732
13.	Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Supportive care Status: Active Age: 2 to 18 Sponsor: Other Protocol IDs: MCW-HRRC-28600, MCW-CHW-0070, NCI-V02-1699, NCT00036712
14.	Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 6 months to 20 years Sponsor: Pharmaceutical / Industry Protocol IDs: TXA127-2010-002, NCT01554254
15.	Clobetasol for Oral Graft-Versus-Host Disease Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 12 to 99 Sponsor: NCI Protocol IDs: 120068, 12-C-0068, NCT01557517
16.	Treatment of Severe Mucositis Pain With Oral Ketamine Mouthwash Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: WVU041011, NCT01566448
17.	Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: OSU-11055, NCI-2012-00459, NCT01653106
18.	Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head and Neck Cancer Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: D1022, NCT01653327
19.	Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 andover Sponsor: Other Protocol IDs: IRB00008071, CPC-12095-L, NCI-2012-02780, NCT01748942
20.	TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation Phase: Phase I Type: Supportive care Status: Active Age: 18 to 60 Sponsor: Pharmaceutical / Industry Protocol IDs: TXA127-2010-001, NCT01300611
21.	Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 20 to 85 Sponsor: Other Protocol IDs: 12.0220, NCT01668849
22.	Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 186-03, ETH136-03D, NCT00206752
23.	TRIAD Burden of Illness Mucositis Study Phase: No phase specified Type: Natural history/Epidemiology, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: No. 200509024, NCT00336609
24.	Dynasplint Therapy for Trismus in Head and Neck Cancer Phase: No phase specified Type: Supportive care Status: Active Age: 20 and over Sponsor: Other Protocol IDs: F07032314, HNO 0602, NCT00507208
25.	Incidence and Factors Associated With the Development and Severity of Oral Mucositis Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HSC20050218H, NCT00575809